EXPERIMENTAL DRUGS / POTENTIAL ANTIBIOTIC THERAPIES AGAINST M. ULCERANS
Roxithromycin
CLASS
Macrolides
MECHANISM OF ACTION
Bacteriostatic
DRUG INTERACTION PHASE (APPROVED, INVESTIGATIONAL, EXPERIMENTAL)
Experimental
MODE OF ADMINISTRATION
Oral
LINK TO PUBMED
https://pubmed.ncbi.nlm.nih.gov/31571947/
SIMILAR TARGETS IN OTHER SPECIES
50S ribosomal protein L10 ~ Shigella flexneri
DRUG BANK ID
DB00778
EXTERNAL LINKS
KEGG Drug D01710 KEGG Compound C13173 PubChem Compound 6915744 PubChem Substance 46507676 ChemSpider 5291557 RxNav 9478 ChEBI 48935 ChEMBL CHEMBL1214185 ZINC ZINC000096006016 Wikipedia Roxithromycin
REFERENCE
Azimi, T., Mosadegh, M., Nasiri, M. J., Sabour, S., Karimaei, S., & Nasser, A. (2019). Phage therapy as a renewed therapeutic approach to mycobacterial infections: a comprehensive review. Infection and Drug Resistance, 12, 2943?2959. https://doi.org/10.2147/IDR.S218638